🎙Good science does not speak for itself. Communities make it move.The ‪@elrig_science‬ Cell & Gene Therapy Conference 2026 demonstrates what happens when scientific meetings are designed around connection rather than competition.This year's conference programme spans neurological disorders, rare disease, and next-generation cancer immunotherapy, while addressing translation, delivery, manufacturing and patient impact. This combination of scientific depth and ecosystem awareness is rare, and increasingly necessary.ELRIG’s #CGT2026 conference is a strong example of how thoughtful design can support meaningful progress.Want to get a behind-the-scenes insight? Then listen now to our podcast interview with one of the conference directors: Dr. Verena Brucklacher.📍 Cambridge | 9–10 March 2026🔗 Register for free at ELRIG Cell & Gene Therapy Conference 2026https://elrig.org/portfolio/cell-gene...%partner&utm_medium=zeeks#ScientificCommunication #ELRIG #CellAndGeneTherapy #Collaboration

In this episode, we had the pleasure of speaking to Prof. Elisabeth Fischer-Friedrich from the Cluster of Excellence 'Physics of Life' at the Technical University Dresden, Germany, about The Role of Mechanical Forces in Health and Disease.

Prof. Fischer-Friedrich talks about her interdisciplinary research investigating how stress and mechanical properties influence biological function and delves into the interplay between intracellular forces, deformation, and dynamic mechanical properties.

Rare diseases rarely come alone.In this episode, we uncover how secondary diseases, infections, and treatment side effects often become as life-changing as the rare diseases themselves.🎧 Hosted by Dr Elisabeth Kugler, this discussion brings together two experts who live and lead in the world of rare conditions — exploring challenges, science, and the human stories behind them.👩‍⚕️ Guests:Sue Farrington• President, ‪@FESCAscleroderma‬ • Chair, ‪@PIF-PatientInformationForum‬ (PiF)• Co-Chair, RAIRDA (Rare Autoimmune Rheumatic Disease Alliance)• Chief Executive, ‪@WeAreSRUK‬ Scleroderma & Raynaud’s UK (SRUK)Dr Jesús Zurdo• Director, Ara Biosciences• #Leukaemia Survivor & Patient Advocate• Non-Executive Director, Telomere Therapeutics• Expert Jury Member, EIC Accelerator Programme